【结 构 式】 |
【分子编号】59596 【品名】2-amino-N-(4-{2-[6,7-dimethoxy-3,4-dihydro-2(1H)-isoquinolinyl]ethyl}phenyl)-4,5-dimethoxybenzamide 【CA登记号】 |
【 分 子 式 】C28H33N3O5 【 分 子 量 】491.58724 【元素组成】C 68.41% H 6.77% N 8.55% O 16.27% |
与该中间体有关的原料药合成路线共 1 条
合成路线1
该中间体在本合成路线中的序号:(V)4,5-Dimethoxy-2-nitrobenzoic acid (I) was converted to the corresponding acid chloride (II) upon treatment with SOCl2, and this was further coupled to aniline (III), producing amide (IV). Catalytic hydrogenation of the nitro group of (IV) afforded amine (V). Acid chloride (VII) --obtained by chlorination of 3-quinolinecarboxylic acid (VI) with SOCl2-- was then condensed with amine (V) to furnish the title diamide.
【2】 Ryder, H.; Ashworth, P.A.; Roe, M.J.; Brumwell, J.E.; Hunjan, S.; Folkes, A.J.; Sanderson, J.T.; Williams, S.; Maximen, L.M. (Xenova Group plc); Anthranilic acid derivs. as multi drug resistance modulators. EP 0934276; GB 2334521; JP 2001502683; US 6218393; WO 9817648 . |
【1】 Roe, M.; et al.; Reversal of P-glycoprotein mediated multidrug resistance by novel anthranilamide derivatives. Bioorg Med Chem Lett 1999, 9, 4, 595. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 31789 | 4,5-dimethoxy-2-nitrobenzoic acid | 4998-07-6 | C9H9NO6 | 详情 | 详情 |
(II) | 31790 | 4,5-dimethoxy-2-nitrobenzoyl chloride | C9H8ClNO5 | 详情 | 详情 | |
(III) | 19194 | 4-[2-[6,7-dimethoxy-3,4-dihydro-2(1H)-isoquinolinyl]ethyl]aniline; 4-[2-[6,7-dimethoxy-3,4-dihydro-2(1H)-isoquinolinyl]ethyl]phenylamine | C19H24N2O2 | 详情 | 详情 | |
(IV) | 59595 | N-(4-{2-[6,7-dimethoxy-3,4-dihydro-2(1H)-isoquinolinyl]ethyl}phenyl)-4,5-dimethoxy-2-nitrobenzamide | C28H31N3O7 | 详情 | 详情 | |
(V) | 59596 | 2-amino-N-(4-{2-[6,7-dimethoxy-3,4-dihydro-2(1H)-isoquinolinyl]ethyl}phenyl)-4,5-dimethoxybenzamide | C28H33N3O5 | 详情 | 详情 | |
(VI) | 59597 | 3-Quinolinecarboxylic acid; Quinoline-3-carboxylic acid | 6480-68-8 | C10H7NO2 | 详情 | 详情 |
(VII) | 59598 | 3-quinolinecarbonyl chloride | C10H6ClNO | 详情 | 详情 |
Extended Information